306 related articles for article (PubMed ID: 7481635)
1. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
Schwery S; Meyenberger C; Ammann R; Wirth HP
Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
[TBL] [Abstract][Full Text] [Related]
2. Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin?
Hundegger K; Stufler M; Karbach U
Z Gastroenterol; 1992 Oct; 30(10):722-8. PubMed ID: 1441675
[TBL] [Abstract][Full Text] [Related]
3. [Initial clinical experiences with a simplified analytic method for fecal alpha-1-antitrypsin].
Fischbach W; Deubel M; Boege F; Mössner J
Z Gastroenterol; 1991 Dec; 29(12):650-4. PubMed ID: 1771947
[TBL] [Abstract][Full Text] [Related]
4. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
Becker K; Niederau C; Frieling T
Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
[TBL] [Abstract][Full Text] [Related]
5. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy].
Colombel JF; Mizon C; Chekkouri N; Balduyck M; Chaussade S; Becuwe C; Degand P; Mizon J; Cortot A
Gastroenterol Clin Biol; 1991; 15(4):301-5. PubMed ID: 2060740
[TBL] [Abstract][Full Text] [Related]
6. Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease.
Thomas DW; Sinatra FR; Merritt RJ
Gastroenterology; 1981 Apr; 80(4):776-82. PubMed ID: 6970702
[TBL] [Abstract][Full Text] [Related]
7. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis.
Jarnum S; Jensen KB
Gastroenterology; 1975 Jun; 68(6):1433-44. PubMed ID: 1132626
[TBL] [Abstract][Full Text] [Related]
8. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
Sugi K; Saitoh O; Hirata I; Katsu K
Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
[TBL] [Abstract][Full Text] [Related]
9. Quantification of fecal alpha 1-antitrypsin excretion for assessment of inflammatory bowel diseases.
Becker K; Frieling T; Häussinger D
Eur J Med Res; 1998 Feb; 3(1-2):65-70. PubMed ID: 9512970
[TBL] [Abstract][Full Text] [Related]
10. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease].
López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651
[TBL] [Abstract][Full Text] [Related]
11. Enteric protein loss in various gastrointestinal diseases determined by intestinal alpha 1-antitrypsin clearance.
Karbach U; Ewe K
Z Gastroenterol; 1989 Jul; 27(7):362-5. PubMed ID: 2475983
[TBL] [Abstract][Full Text] [Related]
12. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
Becker K; Berger M; Niederau C; Frieling T
Hepatogastroenterology; 1999; 46(28):2309-14. PubMed ID: 10521988
[TBL] [Abstract][Full Text] [Related]
13. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
[TBL] [Abstract][Full Text] [Related]
14. Simplified determination of intestinal protein excretion based on alpha 1-antitrypsin clearance.
Karbach U; Singe CC; Ewe K
Z Gastroenterol; 1988 Mar; 26(3):169-73. PubMed ID: 3261475
[TBL] [Abstract][Full Text] [Related]
15. [Increased serum alpha 1-antitrypsin does not produce a rise in fecal alpha 1-antitrypsin in patients with healthy intestines].
Stufler MH; Ewe K; Gierlasinski B; Prün H; Zutt M
Z Gastroenterol; 1991 Jan; 29(1):11-5. PubMed ID: 2058223
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
17. Fecal loss and clearance of alpha-1-antitrypsin in children with persistent diarrhea.
Duarte MA; Carneiro SM; Melo MC; Penna FJ
Braz J Med Biol Res; 1994 Jul; 27(7):1553-60. PubMed ID: 7874022
[TBL] [Abstract][Full Text] [Related]
18. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea.
Fine KD; Ogunji F; George J; Niehaus MD; Guerrant RL
Am J Gastroenterol; 1998 Aug; 93(8):1300-5. PubMed ID: 9707055
[TBL] [Abstract][Full Text] [Related]
19. [Detection of lactoferrin in feces for differential diagnosis in diarrhea].
Fried K; Tárkányi K; Prinz G; Bán E
Orv Hetil; 2002 Sep; 143(37):2141-4. PubMed ID: 12434630
[TBL] [Abstract][Full Text] [Related]
20. Fecal alpha-1-antitrypsin excretion in acute diarrhea: relationship with causative pathogens.
Fontana M; Zuin G; Galli L; Paccagnini S; Villa M; Loguercio L
Helv Paediatr Acta; 1988 Nov; 43(3):211-8. PubMed ID: 3265414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
